CD8A and neoplasm: A study performed on freshly isolated metastatic melanoma samples from two cohorts of 20 patients used flow cytometry alone to show that an increased fraction of tumor-infiltrating CD8+ T cells expressing high level of PD-1 and CTLA-4 strongly correlated with response to therapy and progression-free survival (133).